Developer docs
API playgroundTry for free, no card

Search company profiles

Allied

Full company profile

uuid0005z4i

Namestring
Allied
Legal namestring
Allied Corp.
Websiteurl
allied.health
Company typeenum
Public
Founded yearint
2019
Descriptiontext

Allied Corp is a publicly traded (OTCQB: ALID) B2B supplier of pharmaceutical-grade medical cannabis, founded in 2019 and headquartered in Nevada with its operating base in Kelowna, Canada. The company cultivates cannabis at a 1-hectare GACP-certified greenhouse facility in Mesa de Los Santos, Colombia, operated through wholly owned subsidiary Allied Colombia S.A.S, leveraging Colombia's year-round climate to deliver up to 12 harvests per year and a production capacity of 1,000 kg/month meeting European Pharmacopeia and Australian TGO93 standards.

The core product portfolio comprises smokeable flower with proprietary genetics (Duende, Sundae Stallion, Cherry Popper), EU-GMP-manufactured extracts and finished products (oral solutions in 10:10 and 25:1 formulations, soft gels), and an upcoming Cannabis 2.0 line (gummies, live rosin, vape cartridges). Allied does not own EU-GMP processing assets directly; instead it ships Colombian-grown flower to manufacturing partners Blossom Pharmaceuticals (Portugal), PhytoXtract SA (Switzerland), and Blueberries Medical Corp. (Colombia), which process and distribute under GMP certification.

The business model is multi-year, minimum-volume B2B supply agreements with pharmaceutical distributors in regulated markets. Signed contracts include a 5-year exclusive agreement with CanPoland worth EUR 15.3 million (1,050 kg/year), a 3-year UK distributor agreement with a EUR 360,000 annual minimum, and additional agreements in Australia, Germany, and Switzerland. The go-to-market is sales-led, led by a VP of Global Sales and a Chief Business Development Officer, targeting pharmaceutical companies and licensed medical cannabis distributors across Europe, Australia, and other regulated jurisdictions.

Short descriptiontext

Allied Corp is a publicly traded B2B supplier of pharmaceutical-grade medical cannabis, cultivating GACP-certified flower in Colombia and distributing via EU-GMP partners to pharmaceutical distributors and manufacturers in Europe, Australia, and other regulated markets under multi-year supply agreements.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLas Vegas, United States
HQ citystring
Las Vegas
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis supply, pharmaceutical cannabis cultivation, EU-GMP cannabis processing, cannabis genetics portfolio, cannabis derivative products
Industry1 code
PRIMARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)
NAICS code2 codes
  • Medicinal and Botanical Manufacturing325411
  • Greenhouse, Nursery, and Floriculture Production1114
SIC code2 codes
  • Medicinal Chemicals & Botanical Products2833
  • Pharmaceutical Preparations2834
Product category
Medical Cannabis Cultivation & Supply
Social media profiles1 record
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Cannabis Flower Sales
TypeSubscription Recurring
Description

B2B sales of pharmaceutical-grade cannabis flower to pharmaceutical companies, distributors, and manufacturers. Revenue generated through multi-year supply agreements with minimum volume commitments. Recurring revenue model with signed contracts including 3-year agreements with UK distributor (minimum 200kg/year, €360,000 annual revenue), 3-year agreements worth $750,000, and 5-year exclusive supply agreement with CanPoland worth EUR 15.3 million over 5 years.

allied.health
2Derivative and Extract Products
TypeSubscription Recurring
Description

Sales of EU-GMP manufactured derivative products including extracts, oral solutions (oils with 10:10, 25:1 formulations), soft gels, and finished products through joint venture with Blueberries Medical Corp. and manufacturing partnerships with Blossom and PhytoXtract.

allied.health
3Upcoming Cannabis 2.0 Products
TypeSubscription Recurring
Description

Planned expansion into cannabis-infused products including gummies, live rosin, and vape cartridges manufactured at EU-GMP facilities. Products derived from GACP-certified input materials cultivated in Colombia.

allied.health
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1B2B pharmaceutical-grade cannabis with volume-based minimum commitments
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Multi-year agreements with minimum quarterly order quantities. 3-year UK agreement includes minimum 200kg/year generating €360,000 annual revenue. 5-year CanPoland agreement includes 1,050kg annually of three proprietary genetics.

allied.health
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Allied Inside™
Description

Supply chain business model brand referenced in company materials

allied.health
+1 more record
Core offering1 text field

Allied Corp cultivates pharmaceutical-grade medical cannabis flower in Colombia using proprietary genetics, then supplies the flower and EU-GMP processed derivatives (oral solutions, soft gels) to licensed pharmaceutical companies and medical cannabis distributors globally under multi-year B2B supply agreements. The company maintains a 1-hectare greenhouse facility in Mesa de Los Santos, Colombia with rolling monthly harvests producing up to 1,000 kg/month meeting European Pharmacopeia and TGO93 testing thresholds, processed through EU-GMP partner network.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 457% growth in German cannabis imports (41 tonnes in Q1 2025)
+4 more records
Product overview1 text field

Allied Corp is a medical cannabis supplier offering a portfolio of pharmaceutical-grade cannabis products. The core product lines include Smokeable Flower (premium sun-grown medical cannabis with proprietary genetics), Extracts and Finished Products (EU-GMP oral solutions, oils, and soft gels), and upcoming consumer products (Gummies, Live Rosin, Vape Cartridges). The company also maintains proprietary genetic strains (Duende, Sundae Stallion, Cherry Popper) developed for specific medical conditions. Products are cultivated in Colombia under EU-GACP framework and processed through EU-GMP certified manufacturing partners for distribution to pharmaceutical companies globally.

Product and service2 records
1Smokeable Flower
CategoryMedical Cannabis Flower
Description

Premium sun-grown medical cannabis flower cultivated in climate-controlled greenhouses in Colombia, featuring exclusive proprietary genetic strains. Sold wholesale B2B to pharmaceutical companies and medical cannabis distributors globally. Meets EU-GACP framework standards and European Pharmacopeia testing thresholds.

2Extracts and Finished Products
CategoryMedical Cannabis Derivatives
Description

EU-GMP Pharmaceutical-grade cannabis extracts, oral solutions (oils with 10:10 and 25:1 formulations), and soft gels manufactured through EU-GMP partner network. Input materials cultivated at Colombian facility under EU-GACP framework. Sold B2B to pharmaceutical distributors and manufacturers for medical use.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-11-14
Description

EU-GMP processing and manufacturing partner in Portugal. Handles API and primary processing for Allied's Colombian flower destined for UK, Germany, Poland, and other European markets. Contract manufacturing for flower and derivatives with GMP certification.

Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-10-08
Description

5-year exclusive supply agreement worth EUR 15.3 million. CanPoland, a Polish pharmaceutical and cannabis distributor, will distribute 1,050kg annually of Allied's Colombian-grown cannabis flower across Polish pharmacies. Includes exclusive launch of three proprietary genetics.

3PhytoXtract SA
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2024-09-24
Description

Swiss GMP manufacturing partner with locations in Geneva and Zurich, licensed by Swissmedic. Processes Allied's Colombian-grown cannabis flower into GMP-certified magistral medicinal products for the Swiss market. Adheres to stringent GMP and GDP standards.

allied.health
4UK Licensed Medical Cannabis Distributor
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-01-29
Description

3-year sales and distribution agreement for UK market through EU-GMP manufacturing partner. Includes minimum monthly order quantities and yearly volume commitment of 200kg generating minimum €360,000 annual revenue starting Q1 2025.

allied.health
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2023-11-03
Description

Supply agreements with Australian distributors for THC-based medical cannabis flower meeting TGA standards. Multiple commercial shipments completed since November 2023. Distributors include telehealth clinics and pharmaceutical distributors.

6Swiss GMP Certified Partner
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2023-05-05
Description

Agreement with Swiss Medic narcotics and processing license holder enables Allied's Colombian-produced medical cannabis to be offered into countries requiring GMP-certified products. Partner processes and distributes GMP products across European markets.

allied.health
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-04-26
Description

Joint venture agreement with Blueberries Medical Corp., one of the largest extraction companies in Colombia, to produce psychoactive and non-psychoactive derivative products. Combines Allied's premium quality flower production with Blueberries' leading extraction facilities, enabling derivative-based products alongside flower sales.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

NASDAQ-listed (CLVR) Colombian-based medical cannabis cultivator and EU-GMP certified producer. Direct competitor with similar Colombian low-cost cultivation model targeting European and Australian export markets.

2PharmaCielo
TypeDirect peer
Description

TSXV-listed (PCLO) Colombian cannabis cultivator focused on medical-grade flower and extracts for export. Directly comparable Colombian production base with similar GACP/EU-GMP positioning and target markets.

3Flora Growth
TypeDirect peer
Description

NASDAQ-listed (FLGC) Colombian cannabis cultivator and distributor of pharmaceutical-grade flower and derivatives. Operates similar Colombian cultivation with EU distribution focus.

TypeDirect peer
Description

TSXV-listed (KHRN) vertically-integrated medical cannabis company with Colombian cultivation heritage and European distribution. Competes in similar German, UK, and Latin American markets.

TypeDirect peer
Description

TSX-listed (AVCN) Canadian biopharmaceutical company with Colombian cannabis operations producing pharmaceutical-grade formulations. Directly comparable vertically-integrated producer targeting same medical channels.

TypeDirect peer
Description

Colombian cannabis extraction company and Allied's joint venture partner. Major Colombian extraction player producing psychoactive and non-psychoactive derivatives for export markets.

TypeBroad incumbent
Description

Major Canadian licensed producer (NASDAQ: CGC) with global medical cannabis operations including German and Australian presence. Larger incumbent operating across same end markets but with broader product portfolio.

8Tilray Brands
TypeBroad incumbent
Description

Major global cannabis producer (NASDAQ: TLRY) with strong European medical cannabis footprint, particularly in Germany. Larger established player competing in same regulated medical markets.

TypeBroad incumbent
Description

Canadian licensed producer (NASDAQ: OGI) with European medical cannabis operations. Comparable pharmaceutical-grade production and international distribution model, though at significantly larger scale.

TypeBroad incumbent
Description

Canadian cannabis producer that pivoted away from cultivation, providing a cautionary comparable for the operational and capital challenges facing small-cap cultivators in the medical cannabis space.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration1 record

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles15 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Allied

Medical Cannabis Cultivation & Supplyallied.health

Allied Corp is a publicly traded B2B supplier of pharmaceutical-grade medical cannabis, cultivating GACP-certified flower in Colombia and distributing via EU-GMP partners to pharmaceutical distributors and manufacturers in Europe, Australia, and other regulated markets under multi-year supply agreements.

What Allied does

Allied Corp is a publicly traded (OTCQB: ALID) B2B supplier of pharmaceutical-grade medical cannabis, founded in 2019 and headquartered in Nevada with its operating base in Kelowna, Canada. The company cultivates cannabis at a 1-hectare GACP-certified greenhouse facility in Mesa de Los Santos, Colombia, operated through wholly owned subsidiary Allied Colombia S.A.S, leveraging Colombia's year-round climate to deliver up to 12 harvests per year and a production capacity of 1,000 kg/month meeting European Pharmacopeia and Australian TGO93 standards.

The core product portfolio comprises smokeable flower with proprietary genetics (Duende, Sundae Stallion, Cherry Popper), EU-GMP-manufactured extracts and finished products (oral solutions in 10:10 and 25:1 formulations, soft gels), and an upcoming Cannabis 2.0 line (gummies, live rosin, vape cartridges). Allied does not own EU-GMP processing assets directly; instead it ships Colombian-grown flower to manufacturing partners Blossom Pharmaceuticals (Portugal), PhytoXtract SA (Switzerland), and Blueberries Medical Corp. (Colombia), which process and distribute under GMP certification.

The business model is multi-year, minimum-volume B2B supply agreements with pharmaceutical distributors in regulated markets. Signed contracts include a 5-year exclusive agreement with CanPoland worth EUR 15.3 million (1,050 kg/year), a 3-year UK distributor agreement with a EUR 360,000 annual minimum, and additional agreements in Australia, Germany, and Switzerland. The go-to-market is sales-led, led by a VP of Global Sales and a Chief Business Development Officer, targeting pharmaceutical companies and licensed medical cannabis distributors across Europe, Australia, and other regulated jurisdictions.

Allied firmographics

Firmographics
Name
Allied
Legal name
Allied Corp.
Website
https://allied.health
Company type
Public
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Allied Corp is a publicly traded B2B supplier of pharmaceutical-grade medical cannabis, cultivating GACP-certified flower in Colombia and distributing via EU-GMP partners to pharmaceutical distributors and manufacturers in Europe, Australia, and other regulated markets under multi-year supply agreements.
Ownership category
akta.pro rank

Allied industry classification

Industry
Product category
Medical Cannabis Cultivation & Supply
NAICS
Medicinal and Botanical Manufacturing (325411), Greenhouse, Nursery, and Floriculture Production (1114)
SIC
Medicinal Chemicals & Botanical Products (2833), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYAFAGAGAE
Medicinal Plant Farming (Botanical/Pharmaceutical Crops)
Agriculture & Food Production/Crop Farming/Specialty & Industrial Crop Farming (Tobacco, Hops, Spices, Medicinal/Aromatic Plants)

Keywords

  • Medical cannabis supply
  • Pharmaceutical cannabis cultivation
  • EU-GMP cannabis processing
  • Cannabis genetics portfolio
  • Cannabis derivative products

Where Allied is headquartered

Location

Headquarters

HQ city
Las Vegas
HQ country
United States
HQ region
North America

Offices4 records

Markets served

Allied business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Cannabis Flower Sales: B2B sales of pharmaceutical-grade cannabis flower to pharmaceutical companies, distributors, and manufacturers. Revenue generated through multi-year supply agreements with minimum volume commitments. Recurring revenue model with signed contracts including 3-year agreements with UK distributor (minimum 200kg/year, €360,000 annual revenue), 3-year agreements worth $750,000, and 5-year exclusive supply agreement with CanPoland worth EUR 15.3 million over 5 years.
  2. Derivative and Extract Products: Sales of EU-GMP manufactured derivative products including extracts, oral solutions (oils with 10:10, 25:1 formulations), soft gels, and finished products through joint venture with Blueberries Medical Corp. and manufacturing partnerships with Blossom and PhytoXtract.
  3. Upcoming Cannabis 2.0 Products: Planned expansion into cannabis-infused products including gummies, live rosin, and vape cartridges manufactured at EU-GMP facilities. Products derived from GACP-certified input materials cultivated in Colombia.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractB2B pharmaceutical-grade cannabis with volume-based minimum commitments

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Allied product offering

Product offering

Core offering

Allied Corp cultivates pharmaceutical-grade medical cannabis flower in Colombia using proprietary genetics, then supplies the flower and EU-GMP processed derivatives (oral solutions, soft gels) to licensed pharmaceutical companies and medical cannabis distributors globally under multi-year B2B supply agreements. The company maintains a 1-hectare greenhouse facility in Mesa de Los Santos, Colombia with rolling monthly harvests producing up to 1,000 kg/month meeting European Pharmacopeia and TGO93 testing thresholds, processed through EU-GMP partner network.

Product overview

Allied Corp is a medical cannabis supplier offering a portfolio of pharmaceutical-grade cannabis products. The core product lines include Smokeable Flower (premium sun-grown medical cannabis with proprietary genetics), Extracts and Finished Products (EU-GMP oral solutions, oils, and soft gels), and upcoming consumer products (Gummies, Live Rosin, Vape Cartridges). The company also maintains proprietary genetic strains (Duende, Sundae Stallion, Cherry Popper) developed for specific medical conditions. Products are cultivated in Colombia under EU-GACP framework and processed through EU-GMP certified manufacturing partners for distribution to pharmaceutical companies globally.

Differentiator

Problem solved

Functional benefit

Brands

  • Allied Inside™: Supply chain business model brand referenced in company materials
  • TACTICAL RELIEF™

Products and services

  • Smokeable Flower Premium sun-grown medical cannabis flower cultivated in climate-controlled greenhouses in Colombia, featuring exclusive proprietary genetic strains. Sold wholesale B2B to pharmaceutical companies and medical cannabis distributors globally. Meets EU-GACP framework standards and European Pharmacopeia testing thresholds.
  • Extracts and Finished Products EU-GMP Pharmaceutical-grade cannabis extracts, oral solutions (oils with 10:10 and 25:1 formulations), and soft gels manufactured through EU-GMP partner network. Input materials cultivated at Colombian facility under EU-GACP framework. Sold B2B to pharmaceutical distributors and manufacturers for medical use.

Quantifiable outcome

  • 457% growth in German cannabis imports (41 tonnes in Q1 2025)
  • +4 more outcomes

Companies that use Allied

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles2 records

Allied technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Allied partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core.

  • Blossom Pharmaceuticals (Blossom Genetics)coreImplementation/ SI/ Consulting Partner · 14 November 2024EU-GMP processing and manufacturing partner in Portugal. Handles API and primary processing for Allied's Colombian flower destined for UK, Germany, Poland, and other European markets. Contract manufacturing for flower and derivatives with GMP certification.
  • CanPoland Spółka AkcyjnacoreChannel Partner/ Reseller/ Distributor · 8 October 20245-year exclusive supply agreement worth EUR 15.3 million. CanPoland, a Polish pharmaceutical and cannabis distributor, will distribute 1,050kg annually of Allied's Colombian-grown cannabis flower across Polish pharmacies. Includes exclusive launch of three proprietary genetics.
  • PhytoXtract SAcoreImplementation/ SI/ Consulting Partner · 24 September 2024Swiss GMP manufacturing partner with locations in Geneva and Zurich, licensed by Swissmedic. Processes Allied's Colombian-grown cannabis flower into GMP-certified magistral medicinal products for the Swiss market. Adheres to stringent GMP and GDP standards.
  • UK Licensed Medical Cannabis DistributorcoreChannel Partner/ Reseller/ Distributor · 29 January 20243-year sales and distribution agreement for UK market through EU-GMP manufacturing partner. Includes minimum monthly order quantities and yearly volume commitment of 200kg generating minimum €360,000 annual revenue starting Q1 2025.
  • Australian Pharmaceutical DistributorscoreChannel Partner/ Reseller/ Distributor · 3 November 2023Supply agreements with Australian distributors for THC-based medical cannabis flower meeting TGA standards. Multiple commercial shipments completed since November 2023. Distributors include telehealth clinics and pharmaceutical distributors.
  • Swiss GMP Certified PartnercoreImplementation/ SI/ Consulting Partner · 5 May 2023Agreement with Swiss Medic narcotics and processing license holder enables Allied's Colombian-produced medical cannabis to be offered into countries requiring GMP-certified products. Partner processes and distributes GMP products across European markets.
  • Blueberries Medical Corp.coreStrategic or Co-development Partner · 26 April 2023Joint venture agreement with Blueberries Medical Corp., one of the largest extraction companies in Colombia, to produce psychoactive and non-psychoactive derivative products. Combines Allied's premium quality flower production with Blueberries' leading extraction facilities, enabling derivative-based products alongside flower sales.

Scale indicators10 records

Recent moves7 records

Expansion highlights6 records

Allied competitors and assessment

Company assessment

Direct peers

  • Clever Leaves Holdings: NASDAQ-listed (CLVR) Colombian-based medical cannabis cultivator and EU-GMP certified producer. Direct competitor with similar Colombian low-cost cultivation model targeting European and Australian export markets.
  • PharmaCielo: TSXV-listed (PCLO) Colombian cannabis cultivator focused on medical-grade flower and extracts for export. Directly comparable Colombian production base with similar GACP/EU-GMP positioning and target markets.
  • Flora Growth: NASDAQ-listed (FLGC) Colombian cannabis cultivator and distributor of pharmaceutical-grade flower and derivatives. Operates similar Colombian cultivation with EU distribution focus.
  • Khiron Life Sciences: TSXV-listed (KHRN) vertically-integrated medical cannabis company with Colombian cultivation heritage and European distribution. Competes in similar German, UK, and Latin American markets.
  • Avicanna: TSX-listed (AVCN) Canadian biopharmaceutical company with Colombian cannabis operations producing pharmaceutical-grade formulations. Directly comparable vertically-integrated producer targeting same medical channels.
  • Blueberries Medical Corp. Colombian cannabis extraction company and Allied's joint venture partner. Major Colombian extraction player producing psychoactive and non-psychoactive derivatives for export markets.

Broad incumbents

  • Canopy Growth Corporation: Major Canadian licensed producer (NASDAQ: CGC) with global medical cannabis operations including German and Australian presence. Larger incumbent operating across same end markets but with broader product portfolio.
  • Tilray Brands: Major global cannabis producer (NASDAQ: TLRY) with strong European medical cannabis footprint, particularly in Germany. Larger established player competing in same regulated medical markets.
  • OrganiGram Holdings: Canadian licensed producer (NASDAQ: OGI) with European medical cannabis operations. Comparable pharmaceutical-grade production and international distribution model, though at significantly larger scale.
  • Sundial Growers (now Sunstream USA): Canadian cannabis producer that pivoted away from cultivation, providing a cautionary comparable for the operational and capital challenges facing small-cap cultivators in the medical cannabis space.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

Allied social profiles

Digital presence

Allied compliance and trust

Trust signal

Compliance4 records

Allied financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Allied leadership team

Management profile

Number of profiles

Profiles15 records

Allied subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Allied funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Allied M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Allied

What does Allied do?

Allied Corp cultivates pharmaceutical-grade medical cannabis flower in Colombia using proprietary genetics, then supplies the flower and EU-GMP processed derivatives (oral solutions, soft gels) to licensed pharmaceutical companies and medical cannabis distributors globally under multi-year B2B supply agreements. The company maintains a 1-hectare greenhouse facility in Mesa de Los Santos, Colombia with rolling monthly harvests producing up to 1,000 kg/month meeting European Pharmacopeia and TGO93 testing thresholds, processed through EU-GMP partner network.

Is Allied a public or private company?

Allied is a public company. It is classified as public and is currently operating.

When was Allied founded?

Allied was founded in 2019. It employs 11 to 50 people.

Where is Allied based?

Allied is headquartered in Las Vegas, United States, in the North America region.

How does Allied make money?

Three revenue lines are on record. Medical Cannabis Flower Sales are the primary driver. The others are derivative and Extract Products and upcoming Cannabis 2.0 Products.

Who are Allied's main competitors?

Direct peers on record are Clever Leaves Holdings, PharmaCielo, Flora Growth, Khiron Life Sciences, Avicanna and Blueberries Medical Corp.. Broad incumbents are Canopy Growth Corporation, Tilray Brands, OrganiGram Holdings and Sundial Growers (now Sunstream USA).

Does Allied have an API?

No public API is recorded for Allied.

What industry is Allied in?

Allied's product category is Medical Cannabis Cultivation & Supply. Its primary akta.pro industry code is AFAGAGAE, Medicinal Plant Farming (Botanical/Pharmaceutical Crops). Its NAICS code is 325411 and its SIC code is 2833.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageAllied Provides Corporate UpdateAllied Corp. has received a cease trade order from the British Columbia Securities Commission for failing to file required financial statements, and COO/interim CFO/Director Paul Bullock resigned effective July 27, 2026. The company reports critically constrained liquidity and working capital despite cost reduction measures, while simultaneously experiencing commercial demand exceeding its production capacity. Allied is pursuing financing alternatives outside of Canada and intends to apply to revoke the CTO and cease being a reporting issuer in British Columbia.NewsfileMustang Energy and Allied Strategic Resource Announce Closing of Plan of Arrangement and CSE Conditional Approval for the Allied SharesMustang Energy Corp. completed the previously announced plan of arrangement to spin off Allied Strategic Resource Corp., transferring ownership of uranium properties in Saskatchewan's Athabasca Basin (Ford Lake, Roughrider South, and Cigar East) to Allied in exchange for 6.4 million Allied Shares at a deemed price of $0.05 per share. Mustang shareholders received one new Mustang share plus approximately 0.066 Allied shares for each existing share held, with the arrangement closing on March 27, 2026. Allied has received conditional approval from the Canadian Securities Exchange to list its common shares on the CSE under the ticker symbol ASR, subject to completing customary documentation requirements.Financial PostAllied Announces Closing of $560 Million Marketed Public Offering and Concurrent Private PlacementAllied announced the closing of a $560 million public offering and private placement of its units, raising gross proceeds of $560 million. The offering involved 56 million units at $10 each, conducted with several Canadian financial institutions, and an additional 16 million units were issued to Alberta Investment Management Corporation in a private placement.TradingViewAllied Corp Strengthens Leadership Team to Drive Execution and Global ExpansionAllied Corp., a Canadian cannabis supplier with production in Colombia, announced key leadership appointments including Jim Smeeding as Chairman, Simon Langelier and Abdul Musoke as Directors, and Michael Moses as CEO, aiming to strengthen execution and global expansion in the medical cannabis market. The new management team brings expertise in pharmaceutical compliance, global operations, and regulated market expansion, positioning the company to execute existing commercial contracts and scale operations. The company cited its strategy of leveraging Canadian cultivation expertise with Colombian cost advantages to compete globally as a cost-efficient supplier of pharmaceutical-grade cannabis.SecSEC FORM DThe SEC Form D filing indicates that Allied Corp. is offering securities under Rule 506(c) with a total offering amount of $600,000 and has already sold the same amount. The offering is intended to last less than one year, and a minimum investment of $125,000 is required from outside investors.BenzingaAllied Corp Granted 45,000kgs THC Cannabis Flower and 5000kgs of THC Derivatives Quota - ALLIED CORP by AAllied Corp. has been granted an increased quota for THC cannabis flower from 8,000kgs to 45,000kgs and 5,000kgs of THC derivatives, a development reported on August 31, 2023. This expansion is aimed at enhancing the company's capability to meet growing demand and pursue international market opportunities, with negotiations underway in Australia, Portugal, and Switzerland. The increase validates Allied's position in the cannabis industry and supports its strategic growth plans.